Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global publication plans

Steve Chick OPEN Health

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

OPEN Health

- PMLiVE

Medscape: Education that delivers skin in the game #EADVCongress

Medscape Education Global to Present Symposia and Posters at the European Academy of Dermatology and Venereology 2022 (EADV)

Medscape Education

- PMLiVE

Bristol Myers Squibb’s acute myeloid leukaemia oral maintenance therapy recommended by NICE

Phase 3 trial results show Onureg offers significantly longer overall and relapse-free survival

- PMLiVE

Sanofi and Regeneron share positive data for asthma drug

The trial evaluated the drug for children aged six to 11 years with moderate-to-severe asthma

The Sofa Sessions – Fourth Page

Page & Page Health

- PMLiVE

Qureight announces world’s first digital biomarker for lung fibrosis will ‘transform’ clinical trials

The AI-based Lung8 imaging software picked up differences in response between patients who had an experimental drug compared with those who took a placebo

- PMLiVE

Novavax’s COVID-19 vaccine candidate receives CHMP recommendation for use as a booster

The protein-based vaccine induced a ‘robust antibody response’ when used as a heterologous third booster dose, data from a UK-sponsored trial showed

- PMLiVE

New independent survey shows strong Medscape Professional Network usage among UK doctors

The latest results of the GP and Hospital Doctor Media Surveys reveal that the Medscape Professional Network* (MPN) is amongst the leading destinations for doctors in the UK. Of those surveyed,...

Medscape Education

- PMLiVE

Medscape Oncology: at the core of cancer education #ESMO22

Medscape Education Global to Deliver Educational Opportunities at European Society for Medical Oncology (ESMO) 2022

Medscape Education

- PMLiVE

Pfizer/BioNTech BA.1 COVID-19 booster receives CHMP recommendation

If an authorisation is granted, doses of the bivalent booster will be available to all 27 EU member states

- PMLiVE

Novo Nordisk to acquire Forma Therapeutics in deal worth $1.1bn

The acquisition will focus on expanding the company’s blood disorders portfolio

- PMLiVE

Moderna’s Omicron BA.1 targeting bivalent booster recommended by CHMP for use in EU

Results from a phase 2/3 trial demonstrated mRNA-1273.214 had superior neutralising antibody response against Omicron compared to the currently authorised booster

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links